activeFounded 1979
Boston Scientific Neuromodulation
HQ: Marlborough, MA, USACEO: Mike MahoneyHeadcount: 45,000+ (company-wide)www.bostonscientific.com ↗
Funding Summary
Total Funding
Public (NYSE: BSX)
About
Boston Scientific is a major medical device company with a significant neuromodulation franchise spanning deep brain stimulation, spinal cord stimulation, and sacral neuromodulation. The Vercise Genus DBS system features multi-source current steering for precise therapeutic field shaping. Boston Scientific announced an agreement to acquire Nalu Medical for approximately $533M in October 2025, expanding its neurostimulation portfolio with Nalu's miniaturized peripheral nerve stimulation technology.
Products
bs-vercise-genus
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →